524748 — Link Pharmachem Income Statement
0.000.00%
Last trade - 00:00- IN₹119.90m
- IN₹186.60m
- IN₹274.32m
Annual income statement for Link Pharmachem, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 536 | 388 | 299 | 254 | 274 |
| Cost of Revenue | |||||
| Gross Profit | 93.1 | 174 | 132 | 129 | 134 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 510 | 370 | 316 | 262 | 270 |
| Operating Profit | 26.1 | 17.9 | -16.8 | -8.13 | 4.62 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 26.2 | 8.86 | -19.2 | -14 | 1.35 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 18.8 | 6.54 | -13.6 | -10.3 | 0.769 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 18.8 | 6.54 | -13.6 | -10.3 | 0.769 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 18.8 | 6.54 | -13.6 | -10.3 | 0.769 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 4.05 | 1.47 | -3.18 | -2.31 | 0.17 |